salbutamol

30
Salbutamol Presented By: Ameer hamza shaheed BPD-01093126 Submitted to: Sir Irfan Clinical pharmacology

Upload: bpd01093126

Post on 27-May-2015

2.256 views

Category:

Health & Medicine


4 download

TRANSCRIPT

Page 1: Salbutamol

Salbutamol

Presented By: Ameer hamza shaheedBPD-01093126

Submitted to: Sir Irfan

Clinical pharmacology

Page 2: Salbutamol

SalbutamolDrug name (generic):

SalbutabolTherapeutic class:

Bronchodilator Agent Adrenergic beta-Agonists Tocolytic agent

Pharmacological class: Sympathomimetic (beta2-adrenergic agonist)

Page 3: Salbutamol

Chemical name (IUPAC):

4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol

Chemical structure:

Page 4: Salbutamol

Empirical formula:

C13H21NO3

Pregnancy category: C

Page 5: Salbutamol

Physical properties:

Page 6: Salbutamol

Odour : Odourless

Solubilty: Sparingly soluble in water; soluble in ethanol (96%); slightly soluble in ether.

Colour: A white or almost white, crystalline powder

Page 7: Salbutamol

Pharmacodynamic

Page 8: Salbutamol

Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD.

Salbutamol is formulated as a racemic mixture of the R- and S-isomers.

Page 9: Salbutamol

S-isomer:

R-isomer:

Page 10: Salbutamol

Mechanism of Action

Page 11: Salbutamol

Salbutamol is a beta(2)-adrenergic agonist and thus it stimulates beta(2)-adrenergic receptors.

Salbutamol increases cAMP production by activating adenylate cyclase.

Increased intracellular cyclic AMP increases the activity of cAMP-dependent protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular calcium concentrations.

Page 12: Salbutamol

Mechanism of Action

A lowered intracellular calcium concentration leads to a smooth muscle relaxation and bronchodilation.

Increased cyclic AMP concentrations are also inhibits the release of bronchoconstrictor mediators such as histamine, leukotreine from the mast cells in the airway.

Page 13: Salbutamol
Page 14: Salbutamol

Pharmacokinetics

Page 15: Salbutamol

Pharmacokinetics Bioavailability :oral bioavailability 50%Half life : half life is 4 hours (Taken from rang & dell page 168)

Onset of Action:oral: 30 minutes, Inhalation : 5-15 minutes

Duration of action :

8 to 12 hours(page 361 R&D)

Metabolism : It is subject to first pass metabolism in the liver

Page 16: Salbutamol

Pharmacokinetics

Exretion : Readily excreated in the urine as metabolite and unchanged drug Some excreate in faeces.

Page 17: Salbutamol

Reference Martindale 35th edition page 1016

Page 18: Salbutamol

Clinical uses and Side Effects

Page 19: Salbutamol

f55555555555555555fffffffffffffffffffffff1fffffffffff5Female reproductive

system Relaxation of uterus (during pregnancy)

Page 20: Salbutamol

Reference From nurses drug hand book page 37

Page 21: Salbutamol

Drug Intrections

Page 22: Salbutamol

Contraindication& precaution

Page 23: Salbutamol
Page 24: Salbutamol

Doses

Acute bronchospasm:1 or 2 inhalation of salbutamol i.e 100 microgram 3 or 4 time dailySevere attack of bronchospasm:250 microgram i.v insolution form 10 microgram/mlPremature labour.I.V infusion 200 microgram with 5% gluse used for dilution.

Page 25: Salbutamol

Products for Salbutamol available in market

Page 26: Salbutamol

Brand name Manufacturer Name

Dosage Forms

Ventoline GSK Injection: 0.5 mg Syrupe: 60 mlTablet : 8 mg

Respoline Munawar pharma Tablet : 2 mg

Aeroline Ankaz Syrupe : 60 , 450 MLTablet : 2 , 4 MG

Salbutamol Nawab sons Syrupe : 60 ML

Asmatol Siza Injection : 0.5 MGTablets : 4 MG

Ventomol Venus Tablets : 2 & 3 MG

Page 27: Salbutamol

Reference

Taken from martindale 35th edition page 1016

Page 28: Salbutamol

Reference Pharmaguid page # 1159

Page 29: Salbutamol
Page 30: Salbutamol

Thank you